Pegasys Studies Support NIH Hepa C Consensus

Acknowledging that important advances in hepatitis C therapy have taken place in the last five years, particularly with the introduction of pegylated interferons and ribavirin, the US National Institutes of Health (NIH) recently released a new consensus statement that includes therapy options with a new generation pegylated interferon.

More on this Story

Axis Launches New Health Products

Axis Unlimited Corporation (AUC), a distributor of health and beauty products, recently launched its product lines consisting of nutraceuticals from Japan as well as dermocosmetic skin care products for infants and adults. 

More on this Story

Right Medicine Priced Right Now Available

With the entry of RiteMed Philippines Inc. into the pharmaceutical scene last July 11, a wide array of off-patent drugs is now available, with prices ranging 24 to 81 percent cheaper than the leading brands.  

More on this Story